Clinical Trial Site

Aachen 52074

1 studies enrolling now · 4 studies all time

What they study most

ANCA-Associated Vasculitis, Atypical Hemolytic Uremic Syndrome (aHUS), High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Surgery

Studies at this site

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) — Completed
• Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery — Stopped early